Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89701-89750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05325073
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
PHASE4Active, not recruiting
9 participants
Started: Feb 18, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05285826
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
PHASE3Active, not recruiting
8,100 participants
Started: Feb 18, 2022 · Completed: May 25, 2029
1 condition1 sponsor34 locations
NCT04137757
fMRI in Postural Tachycardia Syndrome
NAActive, not recruiting
21 participants
Started: Feb 18, 2022 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT04851613
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
PHASE3Recruiting
256 participants
Started: Feb 18, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor55 locations
NCT05211895
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
PHASE3Recruiting
860 participants
Started: Feb 18, 2022 · Completed: Sep 12, 2030
1 condition2 sponsors260 locations
NCT05269589
Home-based Heat Therapy for Type 2 Diabetes
NARecruiting
44 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05329727
The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF
N/ARecruiting
1,000,000 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05426187
Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria Vaccine
N/AActive, not recruiting
90 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT05237908
Clinical Outcome and Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages
N/AActive, not recruiting
78 participants
Started: Feb 18, 2022 · Completed: Aug 31, 2028
3 conditions1 sponsor1 location
NCT04985643
A Study of Real Life Treatment for Multiple Myeloma (MM)
N/AActive, not recruiting
357 participants
Started: Feb 18, 2022 · Completed: Jun 20, 2026
1 condition1 sponsor24 locations
NCT04957095
Motor Network Physiology
NARecruiting
120 participants
Started: Feb 18, 2022 · Completed: Dec 1, 2028
2 conditions3 sponsors1 location
NCT05027906
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
PHASE1/PHASE2Recruiting
48 participants
Started: Feb 18, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor9 locations
NCT05450822
Precision Medicine in the Treatment of Epilepsy
N/ARecruiting
550 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT05203224
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
PHASE2Recruiting
300 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05300438
Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.
PHASE1Active, not recruiting
74 participants
Started: Feb 18, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05141877
Influences of Propofol and Sevoflurane Anesthesia in Brain Tumor
PHASE4Recruiting
706 participants
Started: Feb 18, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05145400
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
PHASE2Recruiting
50 participants
Started: Feb 18, 2022 · Completed: Mar 1, 2031
2 conditions2 sponsors5 locations
NCT05168930
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
PHASE2Recruiting
45 participants
Started: Feb 18, 2022 · Completed: Oct 28, 2028
2 conditions2 sponsors4 locations
NCT04971720
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
PHASE2/PHASE3Recruiting
160 participants
Started: Feb 18, 2022 · Completed: Jan 1, 2027
6 conditions2 sponsors1 location
NCT05112315
Clinical Impact of the IBox As an Early Intervention TooL
NAActive, not recruiting
507 participants
Started: Feb 18, 2022 · Completed: Feb 28, 2025
7 conditions1 sponsor16 locations
NCT06102070
Genetic Susceptibility to Severe Infections
N/ARecruiting
2,000 participants
Started: Feb 18, 2022 · Completed: Oct 18, 2038
1 condition1 sponsor1 location
NCT05138393
Scoliosis-specific Exercises for Mild Idiopathic Scoliosis
NARecruiting
90 participants
Started: Feb 18, 2022 · Completed: Nov 30, 2037
1 condition2 sponsors2 locations
NCT05150652
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
PHASE2Recruiting
70 participants
Started: Feb 18, 2022 · Completed: Oct 31, 2036
4 conditions1 sponsor1 location
NCT05247138
Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
N/ARecruiting
142 participants
Started: Feb 18, 2022 · Completed: Jul 1, 2029
1 condition3 sponsors11 locations
NCT05240066
Birth Control to Improve Birth Spacing
N/AActive, not recruiting
1,341 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
4 conditions4 sponsors2 locations
NCT05190705
Loncastuximab Tesirine in WM
PHASE2Recruiting
36 participants
Started: Feb 17, 2022 · Completed: Aug 1, 2028
1 condition2 sponsors4 locations
NCT05299138
Restoring Empowerment and Choosing Hope (REACH)
NARecruiting
900 participants
Started: Feb 17, 2022 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT04975269
Acetazolamide Trial in Normal Pressure Hydrocephalus
PHASE2Active, not recruiting
50 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05291260
RCT on Nonoperative Versus Operative Treatment for Acute Complete tearS of the Ulnar Collateral ligAment of the Thumb
NAActive, not recruiting
126 participants
Started: Feb 17, 2022 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT05128825
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2Recruiting
170 participants
Started: Feb 17, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor70 locations
NCT05017025
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
32 participants
Started: Feb 17, 2022 · Completed: Jun 30, 2026
9 conditions2 sponsors1 location
NCT05245682
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
EARLY_PHASE1Active, not recruiting
10 participants
Started: Feb 17, 2022 · Completed: Oct 21, 2025
6 conditions3 sponsors1 location
NCT05194995
JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation
PHASE1/PHASE2Active, not recruiting
48 participants
Started: Feb 17, 2022 · Completed: Jan 31, 2026
3 conditions1 sponsor17 locations
NCT05469373
ESIS in Pediatric DRE
N/ARecruiting
86 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT05492175
Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation
NARecruiting
72 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05381441
Safety Action Feedback and Engagement (SAFE) Loop
NAEnrolling by invitation
5,163 participants
Started: Feb 17, 2022 · Completed: Jul 31, 2025
2 conditions2 sponsors1 location
NCT05212012
D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations
NCT05992610
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NARecruiting
40 participants
Started: Feb 17, 2022 · Completed: Mar 31, 2026
4 conditions2 sponsors1 location
NCT05416983
Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer
N/AActive, not recruiting
37 participants
Started: Feb 17, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04270838
A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
PHASE1/PHASE2Active, not recruiting
174 participants
Started: Feb 17, 2022 · Completed: Sep 30, 2028
1 condition2 sponsors1 location
NCT04725643
Keep Contraceptive Arm Long Acting-iMplant (CALM) and Carry On
N/AActive, not recruiting
55 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT04772963
Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV)
N/ARecruiting
300 participants
Started: Feb 17, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT04966507
Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention
PHASE2Active, not recruiting
100 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05230537
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
PHASE2Active, not recruiting
170 participants
Started: Feb 17, 2022 · Completed: Oct 2, 2026
1 condition1 sponsor28 locations
NCT04404400
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
PHASE3Recruiting
1,092 participants
Started: Feb 17, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05290038
ARON-2 Study-Multicentric International Retrospective Study
N/ARecruiting
367 participants
Started: Feb 17, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05069922
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation
NARecruiting
100 participants
Started: Feb 17, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT04732091
Therapeutic Use of Contrast Ultrasound in Acute Coronary Artery Disease
N/ARecruiting
540 participants
Started: Feb 17, 2022 · Completed: Feb 1, 2026
2 conditions2 sponsors2 locations
NCT04914611
Real World Assessment of People Living With Chronic Hepatitis B in Australia
N/ARecruiting
10,000 participants
Started: Feb 17, 2022 · Completed: Jul 1, 2027
1 condition1 sponsor19 locations
NCT04917809
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
PHASE2Active, not recruiting
20 participants
Started: Feb 17, 2022 · Completed: Aug 31, 2026
3 conditions1 sponsor7 locations